https://www.selleckchem.com/pr....oducts/ifenprodil-ta
In contrast, doxorubicin, the most common treatment for non-resectable DDLS, reduced tumor growth by 30-50% at a dose that caused weight loss. This high-content screen revealed potential treatments for DDLS. These include irinotecan, which induces apoptosis of DDLS cells in a C/EBPα-dependent, p53-independent manner and should be clinically evaluated in patients with advanced DDLS. This high-content screen revealed potential treatments for DDLS. These include irinotecan, which induces apoptosis of DDLS cells in a C/EBPα-depe
Like
Comment
Share
